Alternative agents to prophylactic platelet transfusion for preventing bleeding in people with thrombocytopenia due to chronic bone marrow failure: a meta-analysis and systematic review (Russian Translation of Cochrane Plain Language Summary)
- Issue: Vol 23, No 4 (2021)
- Pages: 635-636
- Section: CLINICAL ONCOLOGY
- URL: https://journals.rcsi.science/1815-1434/article/view/100145
- DOI: https://doi.org/10.26442/18151434.2021.4.201273
- ID: 100145
Cite item
Full Text
Abstract
This publication is the Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review: Desborough MJR, Hadjinicolaou AV, Chaimani A, Trivella M, Vyas P, Doree C, Hopewell S, Stanworth SJ, Estcourt LJ. Alternative agents to prophylactic platelet transfusion for preventing bleeding in people with thrombocytopenia due to chronic bone marrow failure: a meta-analysis and systematic review. Cochrane Database of Systematic Reviews 2016, Issue 10. Art. No.: CD012055. DOI: 10.1002/14651858.CD012055.pub2
Keywords
benzoates [therapeutic use], bone marrow diseases [complications], chronic disease, deamino arginine vasopressin [therapeutic use], hemorrhage [etiology, prevention & control], hemostatics [therapeutic use], hydrazines [therapeutic use], platelet transfusion, pyrazoles [therapeutic use], randomized controlled trials as topic, receptors, Fc [therapeutic use], recombinant fusion proteins [therapeutic use], thrombocytopenia [complications], thrombopoietin [therapeutic use], tranexamic acid [therapeutic use]